JSPR vs. QQQ
JSPR (Jasper Therapeutics, Inc.) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 3 years, JSPR returned -65.95%/yr vs 27.47%/yr for QQQ. At a 0.21 correlation, their price movements are largely independent.
Performance
JSPR vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JSPR achieves a -72.60% return, which is significantly lower than QQQ's 20.41% return.
JSPR
- 1D
- 10.71%
- 1M
- -44.46%
- YTD
- -72.60%
- 6M
- -73.74%
- 1Y
- -90.26%
- 3Y*
- -65.95%
- 5Y*
- —
- 10Y*
- —
QQQ
- 1D
- -0.25%
- 1M
- 2.96%
- YTD
- 20.41%
- 6M
- 19.46%
- 1Y
- 40.91%
- 3Y*
- 27.47%
- 5Y*
- 16.94%
- 10Y*
- 22.48%
JSPR vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics, Inc. | -72.60% | -91.44% | 170.98% | 63.39% | -93.85% | -37.90% |
QQQ Invesco QQQ ETF | 20.41% | 20.77% | 25.58% | 54.86% | -32.58% | 6.80% |
Correlation
The correlation between JSPR and QQQ is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Sep 24, 2021 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JSPR vs. QQQ — Risk / Return Rank
JSPR
QQQ
JSPR vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JSPR | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.18 | ||
| Sortino ratioReturn per unit of downside risk | -4.91 | ||
| Omega ratioGain probability vs. loss probability | 0.73 | 1.41 | -0.68 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 3.44 | -4.40 |
| Martin ratioReturn relative to average drawdown | -1.23 | 12.79 | -14.02 |
Loading charts...
Drawdowns
JSPR vs. QQQ - Drawdown Comparison
The maximum JSPR drawdown since its inception was -99.72%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for JSPR and QQQ.
Loading charts...
Drawdown Indicators
| JSPR | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.72% | -82.97% | -16.75% |
Max Drawdown (1Y)Largest decline over 1 year | -93.37% | -11.96% | -81.41% |
Max Drawdown (3Y)Largest decline over 3 years | -98.49% | -22.77% | -75.72% |
Max Drawdown (5Y)Largest decline over 5 years | — | -35.12% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -35.12% | — |
Current DrawdownCurrent decline from peak | -99.69% | -0.99% | -98.70% |
Average DrawdownAverage peak-to-trough decline | -88.49% | -32.73% | -55.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 73.29% | 3.21% | +70.08% |
Volatility
JSPR vs. QQQ - Volatility Comparison
Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 48.15% compared to Invesco QQQ ETF (QQQ) at 8.47%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JSPR | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 48.15% | 8.47% | +39.68% |
Volatility (6M)Calculated over the trailing 6-month period | 76.45% | 14.20% | +62.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 106.07% | 17.67% | +88.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 241.69% | 22.64% | +219.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 241.69% | 22.43% | +219.26% |
Dividends
JSPR vs. QQQ - Dividend Comparison
JSPR has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.49%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JSPR Jasper Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ ETF | 0.49% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
Frequently Asked Questions
JSPR and QQQ have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JSPR has higher volatility (48.15%) compared to QQQ (8.47%). In terms of maximum drawdown, JSPR dropped -99.72% vs QQQ's -82.97%.
QQQ currently has the higher Sharpe Ratio (2.33 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JSPR and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer